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Introduction
Colorectal cancer (CRC) is the second most common cause of
cancer mortality in the western world [1]. Individuals with ade-
nomas are at increased risk of developing metachronous ade-
nomas and CRC, even after the adenomas have been complete-
ly removed [2–4]. Therefore, colonoscopy surveillance after po-
lypectomy is recommended [5, 6]. Frequency of colonoscopy
surveillance and adherence to surveillance recommendations
are important, because too little surveillance is associated
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ABSTRACT
Background and study aims Low adherence to the Dutch
guideline for colonoscopy surveillance after polypectomy
led to release of a new guideline in 2013. This new guideline
was risk-stratified at a more detailed level than the previous
one to achieve more efficient use of colonoscopy resources.
This study assessed the feasibility of the risk-stratified
guideline by evaluating correct interpretation of and adher-
ence to this guideline.
Methods Based on semi-structured interviews with 10
gastroenterologists, we developed an online survey to eval-
uate gastroenterologists’ recommendations for surveil-
lance in 15 example cases of patients with polyps. If recom-
mended intervals differed from the new guideline, respon-
dents were asked to indicate their motives for doing so.
Results Ninety-one of 592 (15.4%) invited gastroenterolo-
gists responded to at least one case, of whom 84 (14.2%)
completed the survey. Gastroenterologists gave a correct
recommendation in a median of 10 of 15 cases and adher-
ence per case ranged from 14% to 95% (median case 76%).
The two cases that addressed management of serrated
polyps were least often answered correctly (14% and 28%
correct answers). Discrepancies were mainly due to misin-
terpretation of the guideline with respect to serrated
polyps (48%) or misreading of the questions (30%).
Conclusions Median adherence to the updated colonos-
copy surveillance guideline of 76% seems reasonable, and
is higher than adherence to the previous guideline (range:
22%-80%, median 59%). This shows that detailed (more
complex) risk stratification for designation of a surveillance
interval is feasible. Adherence could potentially be im-
proved by clarifying correct interpretation of serrated
polyps.
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with risk of diminishing the preventive effect of the surveillance
program for CRC, while too intensive surveillance exposes pa-
tients to unnecessary risks and burden and waste of colonosco-
py as well as financial resources.
Colonoscopy is a scarce resource and many countries face
waiting lists for these procedures [7, 8]. With implementation
and expansion of CRC screening programs throughout the
world [9], demand for colonoscopies will further increase.
Before introduction of mass screening, colonoscopies for
surveillance after polypectomy encompassed about 13% of all
colonoscopies conducted in the Netherlands [10]. The recently
begun CRC screening program will result in an increase in ade-
noma diagnoses, eventually resulting in an increasing number
of patients that meet the criteria for surveillance colonoscopy.
This underscores the importance of efficient use of colonosco-
py capacity, and thus, also of efficient surveillance strategies.
Colonoscopy capacity, however, is often not used efficiently
for surveillance. Current international guidelines only consider
presence or absence of risk factors for metachronous advanced
neoplasia, but do not take into account combinations of risk
factors. Several surveys showed suboptimal adherence to
guidelines for surveillance after polypectomy in daily practice,
with clinicians often recommending too short surveillance in-
tervals [11–13]. A Dutch study reported on six example cases
that were assigned correct recommendations ranging from
22% to 80% (median 59%). In most of the incorrect recommen-
dations, gastroenterologists used shorter surveillance intervals
than prescribed by the national guideline [12]. This was caused
by clinicians often incorporating other adenoma characteris-
tics, like adenoma histology and size, into their recommenda-
tion, even though at that time the Dutch surveillance guide-
lines only differentiated the recommended surveillance interval
by adenoma multiplicity [12].
The updated risk-stratified guideline for colonoscopy sur-
veillance introduced in 2013 incorporated multiplicity, size, lo-
cation, and histology of adenomas as well as presence of large
serrated lesions [14]. Through a score chart, these polyp char-
acteristics are combined into a risk score (0–5) to optimize risk
stratification of patients for designation of a surveillance inter-
val. However, this new guideline is more complex than the pre-
vious guideline and most international guidelines. That may
cause gastroenterologists to misunderstand or misinterpret
the guideline, or potentially even not use it all, eventually re-
sulting in low adherence to the recommendations. Therefore,
the aim of our study was to evaluate gastroenterologists' inter-
pretation and adherence to this new guideline.
Materials and methods
Design
To assess correct interpretation of and adherence to the Dutch
guideline for colonoscopy surveillance after polypectomy, we
developed an online survey consisting of 15 example cases of
patients that underwent colonoscopy with polypectomy. The
survey was pilot-tested during semi-structured interviews with
10 gastroenterologists. We sent the survey to all gastroenterol-
ogists in the Netherlands and asked them to designate their
surveillance recommendation for each case. If recommenda-
tion(s) differed from the new guideline, we asked for their mo-
tives for doing so for a maximum of two random example cases.
The survey was estimated to take approximately 15 minutes to
complete and that information was provided to the gastroen-
terologists.
Dutch guideline for colonoscopy surveillance after
polypectomy
The new Dutch guideline for surveillance after polypectomy
was introduced in 2013 [14]. The surveillance interval is based
on the number of adenomas and presence of at least one large
adenoma (≥10mm), at least one villous adenoma (>75% villous
component) and/or at least one proximal adenoma. Serrated
polyps (including hyperplastic polyps, sessile serrated adeno-
mas/polyps and traditional serrated adenoma) are incorpora-
ted in the guideline only if at least one serrated polyp meas-
ures≥10mm. Other characteristics (total number, localization)
of serrated polyps are not taken into account. High-grade dys-
plasia (HGD) in adenomas is not incorporated as a risk factor in
the guideline as it is not confirmed to be an independent risk
factor, probably because HGD is significantly associated with
other factors such as size. Using a score chart, the polyp charac-
teristics are combined into a risk score (0–5) (▶Table1). The
total risk score indicates a recommended surveillance interval
of 3 or 5 years, or no surveillance at all.
Survey
The survey consisted of three parts. The first part (baseline
questions) contained seven questions on (demographic) char-
acteristics of the gastroenterologist: gender; age; type of hos-
pital; specialization; number of colonoscopy procedures per
year; years of experience, and if they perform colonoscopies
for the national screening program.
The second part consisted of 15 example cases of patients
that underwent colonoscopy with polypectomy. To avoid bias
and disadvantages for the later example cases if respondents
could not finish the complete survey, there were two versions
of the survey that only differed regarding the order of the ex-
ample cases. The example cases varied in age, gender, adeno-
ma/polyp number, size and location of adenomas, grade of dys-
plasia and presence of (tubulo)villous histology (▶Table 2,
Appendix 2). Respondents were informed that unless noted
otherwise, all patients were in good health; had no familial risk
for colorectal cancer; had undergone their first colonoscopy;
bowel preparation was good; the cecum was reached; and the
polyp was removed in one piece and endoscopically complete.
In each case, the gastroenterologist was asked to recom-
mend the surveillance interval. Response options were: interval
of < 1 to 10 years; no surveillance; surveillance only if the pa-
tient was in good condition (at a 3- or 5-year interval); and re-
ferral to the clinical geneticist (Appendix 2).
In the third part of the survey, respondents were given feed-
back on the recommendations they had given in Part 2. For
each case in which the recommendation did not meet the
guideline, the respondent was shown a table with the interval
they recommended versus the guideline recommendation.
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Subsequently, respondents were asked about their motives for
deviation for a maximum of two random example cases. Re-
sponse options were: believing that the answer was in agree-
ment with the guideline; not having read the question correct-
ly; unfamiliarity with the new guideline; based on scientific evi-
dence or clinical experience; or an answer in the free text field
(Appendix 2).
Pilot-tests
Interviews
Ten gastroenterologists were interviewed between May and
July 2014 (Appendix 1). The selected gastroenterologists dif-
fered in age, gender, setting (regional or academic hospital),
and region. One of the authors (MvdM) conducted all inter-
views, which were audiotaped. The interviews were semi-struc-
tured, starting with open questions on what gastroenterolo-
gists considered advantages and bottlenecks of the guideline.
Then, they were presented with five cases and asked what inter-
val they would recommend and why. Based on the response of
the interviewed gastroenterologists, the cases were improved
and several answers for why people would potentially deviate
from the current guideline were added.
Online pilot
After enhancement of the survey based on the interview find-
ings, the survey was validated by five medical researchers in
gastroenterology from the Academic Medical Center (AMC)
and the Netherlands Cancer Institute.
Survey distribution
The online survey was sent by email to all 594 registered gas-
troenterologists in the Dutch Gastroenterology Association in
December 2014. A reminder about the survey was sent 6 weeks
later, in January 2015. The survey was anonymous and written
in Dutch.
Statistical analyses
Statistical analyses were conducted with SPSS version 22.0 (IBM
corporation, United States). To be considered as a respondent,
at least four baseline questions had to be answered. Descriptive
statistics were used to analyze the data; medians and interquar-
tile range (IQR) were calculated for non-normally distributed
data. Outcomes were the number of respondents, median
number of correct recommendations per respondent – for
those who responded to all cases -, and the number of correct
recommendations per case. Differences between subgroups in
correct recommendations per respondent were tested with the
Mann-Whitney U test.
Results
Of 592 invitees, 91 (15.4%) responded to at least one case. One
respondent was excluded as he or she did not actively perform
colonoscopies. Of the 91 responders, 84 gastroenterologists
(14.2% of 592 invitees) responded to all cases.
Sixty-five percent of the respondents were male and the me-
dian age was 43 years old (▶Table3). Most respondents worked
in a hospital without gastroenterology trainees (43%), most
had 0 to 10 years of experience (51%), performed more than
300 colonoscopies per year (70%), and performed colonosco-
pies for the national bowel cancer screening program (63%).
Thirty-six percent of respondents indicated that they did not
consult the guideline during the questionnaire, while 48%
used the pocket card for the guideline and 10% used the app.
▶Table 1 Score chart for the Dutch guideline for colonoscopy surveil-
lance after polypectomy [14]
Table 1a: Score table for presence of adenoma characteristics and
serrated polyps1
Polyp Characteristics Values Points
▪ Number of adenomas 1 0
2–4 1
≥5 2
▪ Presence of at least one adeno-
ma≥10mm and/or one large
serrated polyp≥10mm2
No 0
Yes 1
▪ Presence of at least one villous
adenoma3
No 0
Yes 1
▪ Presence of at least one proximal
adenoma4
No 0
Yes 1
Total risk score
Table 1b: Surveillance interval based on the adenoma risk score
Score during index colonoscopy Interval after index colonos-
copy
▪ 0 No surveillance5
▪ 1–2 5 years
▪ 3–5 3 years
Score during subsequent colonos-
copy
Interval after subsequent
colonoscopy
▪ 0 5 years6
▪ 1–2 5 years
▪ 3–5 3 years
Stopping age of surveillance: 75 years, unless the wish and condition
of the patient justify a different stopping age
1 A patient with 5 proximal serrated polyps of which 2≥10mm fulfil the
WHO criteria of the serrated polyposis syndrom; see the guideline of her-
editary colorectal cancer.
2 A serrated polyp encompasses: hyperplastic polyps, sessile serrated
polyps/adenomas and traditional serrated adenomas
3 An adenoma with at least 75% villous histology.
4 Proximal is defined as cecum, colon ascendens, colon transversum and
flexura lienalis
5 Patients with a score of 0 during index colonoscopy are advised to not un-
dergo surveillance colonoscopy. These patient are sent back to the national
screening programme in 10 years if aged 55–75 years at that moment.
6 For patients in which a high-risk adenoma (score≥3) was never detected,
surveillance can be ended after two subsequent negative colonoscopies.
These patient are sent back to the national screening programme in 10
years if aged 55–75 years at that moment.
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▶Table 2 Short description of the 15 example cases with recommended interval and results per example case.
Case description Results per case
Common cases
Age G # AD1 Size
(mm)
Vill. HGD #
prox1
Recommen-
ded interval
N % corr % early % late % no
surv
% other
 1 60 M 1  8 T no 0 No surveil-
lance
  86 84% 16%  0% na  0%
 2 69 M 1 12 T no 0 5y   89 91%  1%  1%  3%  3%
 3 54 M 1 202 TV no 1 5y   85 52% 47%  1%  0%  0%
 4 62 F 2 222 V no 0 3y   84 79%  6% 15%  0%  0%
 5 63 F 4  9 V no 2 3y   84 90%  0%  7%  0%  2%
 6 60 F 5 12 T no 4 3y   84 95%  2%  1%  0%  1%
 7 79 M 5  8 T no 3 Only if heal-
thy, then 3y3
  84 52%  1%  8% 11% 27%
 8 75 M 4 12 T yes 0 Only if heal-
thy, then 5y3
  84 31% 40%  0%  4% 25%
 9 65 M 1 11 TV yes 0 5y   88 76% 17%4  1%  2%  3%
Serrated adenomas/polyps
Age G # SP1 Size
(mm)
#
prox1
N % corr % early % late %no
surv
% other
10 58 F 1  8 1 No surveil-
lance
  85 14% 86%  0% na  0%
11 54 F 2 12 2 5y   86 28% 72%  0%  0%  0%
Family history
Age G Score FM Age
FM
Previous exami-
nation
N % corr % early % late % no
surv
% other
12 51 M 2 Brother < 50 Yes, no heredi-
tary CRC
5y   84 83% 14%  0%  0%  2%
13 53 M 1 Sister < 50 no Refer to ge-
neticist
  88 58%  0%  0%  0% 42%
Negative colonoscopies
Age G Initial
Score
# neg. colo1 N % corr % early % late % no
surv
% other
14 69 M 45  1 5y   86 88%  5%  2%  3%  1%
15 63 F 25  2 No surveil-
lance
  86 73% 23%  0% na  3%
TOTAL 1283 66% 22%  3%  2%  7%
G, gender; # AD, the number of adenomas; Size, size of the largest lesion Vill, presence of villousness; T, tubular adenoma; TV, tubulovillous adenoma; V, villous
adenoma; HGD, presence of high-grade dysplasia
1 prox, the number of proximal adenomas; #SP, number of serrated polyps; FM, family member with CRC diagnoses. # neg. colo =number of previous negative co-
lonoscopies; % corr =% of answers correct, according to the guideline (underlined≤50% correct, italic≤70% correct) % early =% of answers with a shorter interval
than recommended; % late =% of answers with a longer interval than recommended; % no surv =% of answers with no surveillance while this is not recommended;
% other =% of answers with another answer (underlined≥40% of respondents, italic≥15% of respondents)
2 In the cases with adenomas≥20mm we describe that patients had had another colonoscopy after 6 months at which no residual tissue was found.
3 If an individual will be 75 at the subsequent screening, then surveillance should only take place if the individual is still healthy, and an interval is based on the ade-
noma risk score. We defined all answers containing a shorter interval then recommend based on the adenoma risk score as “early”, we defined all answers con-
taining a longer interval then recommend based on the adenoma risk score as “late” and an answer with the same interval but without the addition that the patient
should only be screened if healthy as “other”.
4 10 of 15 of the respondents with an answer with a too short interval, answered they would offer a surveillance colonoscopy within a year.
5 Full findings at the initial colonoscopy were: 69-year-old male: two adenomas: Polyp A was a distal villous adenoma of 12mm. Polyp B was a proximal tubular ade-
noma of 8mm with low-grade dysplasia; 63-year-old female: two adenomas: Polyp A was a distal tubular adenoma of 5mm with low-grade dysplasia. Polyp B was a
distal tubular adenoma of 12mm with low-grade dysplasia.
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Eighty-four respondents indicated correct recommenda-
tions for all cases in a median of 10 (out of 15) cases (IQR 8–
11) (▶Table 4 and ▶Fig. 1). The number of correct recommen-
dations did not differ by gender, age, type of hospital, or parti-
cipation in the screening program, but consulting the guideline
during the questionnaire was associated with an increase in ad-
herence (P=0.015).
The cases received a correct recommendation ranging from
14% to 95% per case (median case 76%) (▶Table2). For all
cases combined, a mean of 66% of recommendations were cor-
rect, 22% of the recommended intervals were shorter than the
guideline, 3% of the given recommended intervals were longer
than the guideline, 7% gave no surveillance interval, but an al-
ternative recommendation while a surveillance interval was re-
commended (such as referral to a clinical geneticist, or only re-
ferral if the patients was in good condition) and 2% recommen-
ded no surveillance at all while the guideline did recommend
surveillance. In 48% of the discrepant cases, gastroenterolo-
gists were convinced they had recommended the correct inter-
val, while in 30% of the discrepant cases, gastroenterologists
had not read the question correctly (▶Table 5).
The recommendation for surveillance was least often correct
for the cases on serrated lesions (case 10, 14% correct, and case
11, 28% correct) (▶Table 2). All discrepant answers recom-
mended a shorter interval (86% and 72%) of which 92% and
95% recommended the interval that would be correct if serra-
ted polyps were scored the same as conventional adenomas. In
78% and 65%, respectively, of these discrepant cases, gastro-
enterologists had the impression they had recommended the
correct interval. Thirteen percent and 26%, respectively,
answered that they had not read the question correctly (▶Ta-
ble5).
Next, cases with an older patient (≥75 years) were least of-
ten answered correctly, at 31% for Case 8 and 52% for Case 7
(▶Table2). In the case of a 75-year-old male with four adeno-
mas and one adenoma with HGD (Case 8), 40% of respondents
recommended a shorter interval than the guideline and 25% of
respondents recommended surveillance after 5 years. Respon-
ders explained their discrepancy with the guideline for these
cases because they were either convinced their answer was in
accordance with the guideline or they had not read the ques-
tion correctly (▶Table 5). Of those who provided an answer for
Cases 7 and 8 in the free text field, 12 of 14 mentioned they did
not consider age or the condition of the older patient in their
answer. In the case of a 79-year-old male with five adenomas
(Case 7), the correct answer would be to recommend no sur-
veillance, unless the patient remains in good condition, then in
3 years. Eleven percent of respondents would not recommend
any surveillance regardless of physical condition, and 26% of re-
spondents recommended surveillance after 3 years. If you as-
sume that after these 3 years, everyone would examine these
older patients if they are still in good condition, 78% of cases
would be answered correctly.
The case with a large tubulovillous adenoma (Case 3) was
correctly answered by only half (52%) of the gastroenterolo-
gists. If incorrect, recommended intervals were almost always
too short (▶Table 2). Discrepancies were again mainly due to
misinterpretation of the guideline (62%). Three of four answers
in the free text field explained that they scored the tubulovil-
lous adenoma equal to villous adenoma.
▶Table 3 Baseline characteristics of respondents (N=91).
Variable N=99
Age (median) 43 (IQR 35–52)
Gender
▪ Males 64 65%
▪ Females 35 35%
Type of hospital
▪ Academic 19 19%
▪ Non-academical teaching hospital 37 38%
▪ Peripheral hospital 42 43%
▪ Missing  1
Specialization
▪ Gastroenterologist 92 95%
▪ Fellow  5  5%
▪ Missing  2
Years of experience with colonoscopies
▪ No experience  2  2%
▪ 0 to 10 50 51%
▪ 10 to 20 21 21%
▪ 20 to 30 18 18%
▪ 30 to 40  6  6%
▪ >40  2  2%
Colonoscopies per year
▪ <150 10 10%
▪ 150–300 19 20%
▪ >300 68 70%
▪ Missing  2
Performing colonoscopies for the screening program
▪ Yes 61 63%
▪ No 36 37%
▪ Missing  2
Use of source during questionnaire
▪ None 29 36%
▪ App  8 10%
▪ Pocket card 39 48%
▪ Website  2  2%
▪ 2 sources  3  4%
▪ Missing 18
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Remarkable about the case of the 65-year-old male with one
adenoma with HGD (Case 9) was that even though 76% of the
respondents answered correctly, the incorrect answers had a
large discrepancy with the interval recommended by the guide-
line. Eleven percent of the respondents recommended surveil-
lance colonoscopy within 1 year, whereas a 5-year interval is re-
commended by the guideline. Two of six gastroenterologists
that explained their discrepancy from the guideline for this
case responded that they consider lesions with HGD as high
risk.
A new aspect in the guideline is that no surveillance is indi-
cated if patients have only one distal non-advanced adenoma
(Case 1). This was correctly recommended by 84% of respon-
dents.
The remaining eight cases were correctly answered by a me-
dian of 86% (58% to 95% per case) of the respondents.
Discussion
Using a survey with 15 example cases, we showed that the
cases were assigned a recommend surveillance interval in
agreement with the current guideline in 14% to 95% per case
(median case 76%) and the gastroenterologists gave a correct
recommendation in a median of 10 cases. Cases involving serra-
ted polyps or elderly patients were most often answered incor-
rectly.
As large interobserver and intraobserver variation exists
among pathologists for diagnosis of various types of serrated
polyps, serrated polyps are treated as one histological entity in
the guideline. To prevent patients with only small hyperplastic
polyps from receiving a surveillance recommendation, number
and location of serrated polyps does not impact length of sur-
veillance interval in the guideline [14]. In our survey, almost all
discrepant recommendations would have been correct if serra-
ted polyps were scored the same way as conventional adeno-
mas. We therefore recommend providing further clarification
in the guideline on how to deal with serrated polyps. This could
potentially be accompanied by further teaching sessions, for
example, an e-learning course for gastroenterologists is already
implemented.
Before developing the survey, we hypothesized three other
instances in which gastroenterologists might deviate from the
guideline: cases with adenomas with high-grade dysplasia,
cases with tubulovillous adenomas, and cases where the guide-
line recommends returning to the national CRC screening pro-
gram with fecal immunochemical test. Although cases invol-
ving HGD were answered according to the guideline by a major-
ity of respondents, the gastroenterologists who did not answer
in line with the guideline recommended an interval shorter
than 1 year. In the US surveillance guideline and the guideline
from the European Society of Gastrointestinal Endoscopy, HGD
is considered a high-risk feature [6, 15]. However, in the Dutch
guideline, HGD is not incorporated as a separate risk factor, be-
▶Table 4 Score (median correct recommendations according to the guideline) of 15 example cases of respondents to all example cases (n =84).
N Score out of 15 cases P value
Gender Men 51 10
Women 33 10 0.81
Age <40 37 11
>40 47 10 0.62
Academic hospital Yes 16 11
No 67 10 0.44
Performing colonoscopies for the CRC screening program1 Yes 51 11
No 31 10 0.71
Use of source1
Yes 29 11
No 52  9 0.02
Total 10
1 Either use of no source at all, or use of the app, pocket card and/or website.
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▶ Fig. 1 Distribution of scores for 15 example cases (number of
correct answers according to the guideline) from respondents who
answered all example cases (n =84).
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cause a meta-analysis and the study on which the guideline was
based did not confirm HGD as an independent risk factor in ad-
dition to the other factors [4, 16]. This is mainly explained by
the fact that HGD is rarely seen in small (< 10mm) tubular or tu-
bulovillous adenoma. Furthermore, there is significant interob-
server variation between pathologists, making this feature an
unreliable risk factor. In the interviews, half the gastroenterolo-
gists mentioned that they were not entirely convinced that
HGD should not be incorporated, while one gastroenterologist
in the interview specifically mentioned that HGD was not incor-
▶Table 5 Short description of the 15 example cases with the recommended interval and rationale for deviating from the guideline.
Case Description Rationale for Deviation From Guideline
Common cases
Age G # AD Size
(mm)
Vill. HGD # prox Recommen-
ded interval
N % ex-
pected
to be
correct
% based
on clini-
cal ex-
perience
% did
not
read
cor-
rectly
% other
 1 60 M 1  8 T no 0 No surveillance   6  0% 17%  83%  0%
 2 69 M 1 12 T no 0 5y   0
 3 54 M 1 20 TV no 1 5y  21 62% 10%  10% 19%1
 4 62 F 2 22 V no 0 3y   6 50% 17%  33%  0%
 5 63 F 4  9 V no 2 3y   4 50%  0%  50%  0%
 6 60 F 5 12 T no 4 3y   1  0%  0% 100%  0%
 7 79 M 5  8 T no 3 Only if healthy,
then 3y
 16 25%  0%  31% 44%2
 8 75 M 4 12 T yes 0 Only if healthy,
then 5y
 25 32%  0%  44% 24%2
 9 65 M 1 11 TV yes 0 5y   6 50%  0%  17% 33%3
Serrated adenomas/polyps
Age G # SP Size
(mm)
# prox N
10 58 F 1  8 1 No surveillance  23 78%  0%  13%  9%
11 54 F 2 12 2 5y  23 65%  4%  26%  4%
Family history
Age G Score FM Age
FM
Previous
examination
N
12 51 M 2 Brother < 50 Yes, no hereditary
CRC
5y   6 17% 17%  50% 17%
13 53 M 1 Sister < 50 no Refer to ge-
neticist
 11 18%  9%  36% 36%
Negative colonoscopies
Age G Initial
Score
# neg. colo N
14 69 M 4  1 5y   3 67%  0%  33%  0%
15 63 F 2  2 No surveillance   6 83%  0%  17%  0%
Total 157 48%  4%  30% 17%
G, gender; # AD, the number of adenomas; Size, size of the largest lesion; Villi, presence of villousness; T, tubular adenoma; TV, tubulovillous adenoma; V, villous
adenoma; HGD, presence of high-grade dysplasia; # prox, number of proximal adenomas; # SP, number of serrated polyps; FM, family member with CRC diagnoses;
# neg. colo, number of previous negative colonoscopies; N, number of answers per case.
1 3 of 4 respondents answered that they scored the tubulovillous adenoma as a villous adenoma.
2 12 out of 14 other answers incorporated the age of the patient in their answer.
3 Both (2) respondents mentioned they saw HGD as high risk.
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porated in this score chart, but should be considered as high-
risk, assigning a surveillance interval within 1 year.
Discrepancies for cases with a (tubulo)villous adenoma
seemed to be caused by gastroenterologists scoring tubulovil-
lous adenomas as villous adenomas. However, in previous stud-
ies, a tubulovillous adenoma (>25% and<75% villous compo-
nent) was not a risk factor for metachronous disease in a multi-
variable model [4, 17]. Only villous adenoma (>75% villous
component) was found to be a risk factor [16], and therefore
assigned an extra point to the risk score chart in the guideline.
However, that might be confusing because internationally an
advanced adenoma is defined as an adenoma ≥10mm, HGD,
or a tubulovillous component (> 25%). Also, during the inter-
views, six of 10 gastroenterologists mentioned that adhering
to the guideline was difficult considering the difference be-
tween tubulovillous and villous adenomas, because pathology
reports in their hospital do not include percentages nor wheth-
er adenomas were villous or tubulovillous (Appendix 1).
In contrast to the cases discussed before, the case in which a
person with only one distal non-advanced adenoma should re-
turn to the screening program was answered correctly by a
large majority without striking discrepancies. Previously these
patients would be recommended surveillance after 6 years,
but apparently the change to recommend no surveillance is
well accepted.
Adherence to our colonoscopy surveillance guideline is at
the high end of adherence as reported in other studies. Median
adherence to the guideline was reported to be 49% in France,
63% in Canada and 52.5% and 69% in the United States in two
different periods. A study in the United States in primary care
physicians found a far lower adherence of 29% [11–13, 18–
20]. More specifically, compared to the reported adherence in
the Netherlands when the simple 2002 guideline was imple-
mented, our estimate of adherence shows a clear increase
with a median of 76% adherence, compared to [12] a median
of 59% (range: 22%–80%) in the survey based on the old guide-
line. This comparison clearly indicates that more complex
guidelines do not necessarily lead to confusion and lower ad-
herence, but that they might actually increase adherence. The
reasons were not explored in our study, but possibly it is be-
cause they better align with physicians’ clinical experience and
international literature and guidelines.
An important strength of our study is that we based the sur-
vey on a pilot that consisted of interviews with 10 gastroenter-
ologists, and that the pilot provided insight into which situa-
tions led to deviation from the guideline and the rationale for
the deviation. However, our study also has three limitations.
First, the response rate to the survey was low, which may have
led to non-respondent bias. We did not see any differences in
age and gender between respondents and the complete group
and the number of correctly answered questions did not show a
skewed distribution. Still, non-response bias could exist, given
that the proportion of responding gastroenterologists was low-
er in academic hospitals (9.4%) compared to other types of
hospital (18.0%). Previous studies have shown that adherence
to guidelines is generally higher in academic hospitals, implying
that we may have underestimated the adherence rate. On the
other hand, some respondents asked for development of an e-
learning module of this survey, indicating that at least some of
the responding endoscopists were eager to improve their
knowledge about the guideline and were thus more likely to fol-
low it. In that case, the estimated adherence rate could be over-
estimated.
Second, we only measured adherence to guidelines among
gastroenterologists. This is not a limitation in the Netherlands,
because there the vast majority of surveillance endoscopies are
performed by gastroenterologists. However, it may hamper the
generalizability of our findings to other settings where surveil-
lance endoscopies may also be performed by surgeons or inter-
nists. If these clinicians have less knowledge about surveillance
guidelines, adherence to guidelines may be lower in these set-
tings.
Finally, our findings are based on a survey, while adherence
in daily practice may be different for various reasons. It would
be preferable to measure actual adherence rates. In a survey,
gastroenterologists might give desirable answers although
they deviate from guidelines in daily practice. Also, if a recom-
mendation is given to a patient, the patient does not always
show up after the correct interval.
Our study has four important practical implications. First,
the fact that the most often quoted rationale for deviation
from the guideline was misinterpretation for cases with serra-
ted polyps clearly indicates that information about these polyps
on the score chart or app needs to be improved. Second, it
should be further highlighted that according to the guideline,
HGD should not be taken into account when determining the
interval. Moreover, gastroenterologists and pathologists need
to discuss how to improve reporting of the villous or tubulovil-
lous nature of an adenoma in the pathology report to facilitate
classification of these lesions. At the time the national colorec-
tal cancer screening program was introduced in 2014, proto-
cols for structured endoscopy and pathology reports were also
introduced with predefined categories for histology, which may
improve classification of villous or tubulovillous adenoma. Fi-
nally, use of a pocket-sized score chart, app or other source
when making surveillance interval recommendations should
be encouraged as this improves adherence to the guideline.
It would be even better if, in the future, software could be
integrated into the electronic patient dossier that would auto-
matically determine the recommended surveillance interval
based on registered polyp characteristics. That would improve
interpretation of the guideline and noncompliance with it
would require a manual override of the system.
The current Dutch guideline differs from other guidelines re-
garding level of risk stratification. While other guidelines divide
patients into groups based on a simple heuristic using presence
or absence of risk factors [6, 21, 22] the Dutch guideline com-
bines several risk factors into a score from 0 to 5. The Dutch
guideline is therefore more complex, which may cause misun-
derstandings and thereby decrease adherence. However, this
study showed that more complexity in a guideline did not lower
adherence as assessed in a survey, and that this guideline with
risk stratification actually seemed to improve adherence. Be-
cause better risk-stratification leads to efficient use of sources
E1412 van der Meulen Miriam P et al. Interpretation and adherence… Endoscopy International Open 2020; 08: E1405–E1413 | © 2020. The Author(s).
Original article
and less unnecessary colonoscopies, this should encourage
other countries to implement a guideline with more detailed
risk-stratification.
Conclusion
In conclusion, median adherence to the updated colonoscopy
surveillance guideline of 76% seems reasonable, and is higher
than adherence to the previous guideline. This shows that de-
tailed (more complex) risk stratification for designation of a
surveillance interval is feasible. Adherence could potentially be
improved by clarifying the correct interpretation of serrated
polyps.
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